课题基金 / 基金详情

NEUROPEPTIDES: MOLECULAR MECHANISM OF ACTION

NEUROPEPTIDES: MOLECULAR MECHANISM OF ACTION
神经肽:分子作用机制
批准号:
3918772
负责人:
L H LAZARUS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

L H LAZARUS的其他基金

相似基金

相关文献

中文摘要
翻译
德吗啡(DM),一种两栖阿片类七肽,含有 2位天然D-丙氨酸,N-末端DM类似物及系列 二聚体DM类似物(通过C-末端偶联)是 大鼠脑内Mu和Delta受体亲和力的分析 突触体。结合试验用~3H-DAGO测定MU受体和 β受体的3HDADLE(在N-Me-Me存在下进行) Phe3,D-Pro4)吗啡抑制与Mu-2的相互作用 受体)。二聚体DM四肽与Mu-2相互作用弱 受体;特别是具有12个亚甲基单元的类似物 多肽链之间的桥联具有较差的Mu和Delta亲和力 而且没有选择性。然而,与乙烯桥类似 含有D-Arg2和Sar4具有高的Mu亲和力、Mu选择性, 与抑制胃酸分泌有关。全 二聚体DM五肽具有很高的表观亲和力, 中等至低的MU选择性,但呈正相关 对胃液分泌的抑制。鉴于D-Arg和Sar 增加了二聚体四肽中的MU亲和力和选择性, 他们降低了五肽中的这些参数。二聚体DM DM对Mu受体具有较高的亲和力和选择性 接近DAG0,与抑制性呈正相关 在胃分泌过程中的作用。作为对 结合特异性,(L-阿拉斯加)DM类似物被测试:它结合 对亲和力小于3个数量级的Mu受体 DM,这与其最低生物活性是一致的。因此,这些 研究表明,大脑中的高亲和力Mu受体 组织与胃的抑制呈正相关 中枢(Icv)给药引起的胃酸排出量 和精选的二聚体DM类似物。
英文摘要
Dermorphin (DM), an amphibian opioid heptapeptide which contains a natural D-Ala in position 2, N-terminal DM analogues and a series of dimeric DM analogues (coupled through the C-terminus) were analyzed for mu- and delta-receptor affinities on rat brain synaptosomes. Binding assays used 3H-DAGO for mu-receptors and 3HDADLE for delta-receptors (carried out in the presence of (N-Me- Phe3,D-Pro4) morphiceptin to suppress interaction with mu- receptors). Dimeric DM tetrapeptides weakly interacted with mu- receptors; in particular, the analogue with a 12 methylene unit bridge between peptide chains had poor mu- and delta-affinities and no selectivity. However, analogue with an ethylene bridge containing D-Arg2 and Sar4 had high mu-affinity, mu-selectivity, and correlated to the inhibition of gastric acid secretion. All the dimeric DM pentapeptides had very high mu-affinities, with moderate to low mu-selectivity, but correlated in a positive manner to the suppression of gastric secretion. Whereas D-Arg and Sar increased mu-affinity and selectivity in the dimeric tetrapeptides, they decreased these parameters in the pentapeptides. Dimeric DM and DM exhibited high affinity for mu-receptors and selectivity approaching DAG0 and had a positive correlation to the inhibitory effect in the gastric secretory process. As a control for the binding specificity, the (L-Ala2)DM analogue was tested: it bound to mu-receptors with an affinity 3-orders of magnitude less than DM, which is in keeping with its minimal bioactivity. Thus, these studies provide evidence that high affinity mu-receptors in brain tissue correlate in a positive manner to the inhibition of gastric acid output in stomach by the central (icv) administration of DM and selected dimeric DM analogues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR DYNAMICS CONFORMATION OF OPIOID PEPTIDES
NEUROPEPTIDES--MOLECULAR MECHANISM OF ACTION
MOLECULAR DYNAMICS CONFORMATION OF OPIOID PEPTIDES
NEUROREGULATORY ASPECTS OF NEUROMEDIN B
海外基金